Structure-Based Reassessment of the Caveolin Signaling Model: Do Caveolae Regulate Signaling through Caveolin-Protein Interactions?

被引:111
作者
Collins, Brett M. [1 ]
Davis, Melissa J. [1 ,3 ]
Hancock, John F. [4 ]
Parton, Robert G. [1 ,2 ]
机构
[1] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia
[2] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia
[3] Univ Queensland, Queensland Facil Adv Bioinformat, Brisbane, Qld 4072, Australia
[4] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA
基金
澳大利亚国家健康与医学研究理事会; 澳大利亚研究理事会; 英国医学研究理事会; 美国国家卫生研究院;
关键词
NITRIC-OXIDE SYNTHASE; TYROSINE KINASE DOMAIN; NICOTINIC ACETYLCHOLINE-RECEPTOR; HIV-1 GLYCOPROTEIN GP41; MURINE LEUKEMIA-VIRUS; CRYSTAL-STRUCTURE; SCAFFOLDING DOMAIN; BINDING DOMAIN; ANGSTROM RESOLUTION; PLASMA-MEMBRANE;
D O I
10.1016/j.devcel.2012.06.012
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Caveolin proteins drive formation of caveolae, specialized cell-surface microdomains that influence cell signaling. Signaling proteins are proposed to use conserved caveolin-binding motifs (CBMs) to associate with caveolae via the caveolin scaffolding domain (CSD). However, structural and bioinformatic analyses argue against such direct physical interactions: in the majority of signaling proteins, the CBM is buried and inaccessible. Putative CBMs do not form a common structure for caveolin recognition, are not enriched among caveolin-binding proteins, and are even more common in yeast, which lack caveolae. We propose that CBM/CSD-dependent interactions are unlikely to mediate caveolar signaling, and the basis for signaling effects should therefore be reassessed.
引用
收藏
页码:11 / 20
页数:10
相关论文
共 111 条
  • [1] Structural basis for inhibition of protein-tyrosine phosphatase 1B by isothiazolidinone heterocyclic phosphonate mimetics
    Ala, Paul J.
    Gonneville, Lucie
    Hillman, Milton C.
    Becker-Pasha, Mary
    Wei, Min
    Reid, Brian G.
    Klabe, Ronald
    Yue, Eddy W.
    Wayland, Brian
    Douty, Brent
    Polam, Padmaja
    Wasserman, Zelda
    Bower, Michael
    Combs, Andrew P.
    Burn, Timothy C.
    Hollis, Gregory F.
    Wynn, Richard
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (43) : 32784 - 32795
  • [2] Slo1 caveolin-binding motif, a mechanism of caveolin-1-Slo1 interaction regulating Slo1 surface expression
    Alioua, Abderrahmane
    Lu, Rong
    Kumar, Yogesh
    Eghbali, Mansoureh
    Kundu, Pallob
    Toro, Ligia
    Stefani, Enrico
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (08) : 4808 - 4817
  • [3] Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
    Aller, Stephen G.
    Yu, Jodie
    Ward, Andrew
    Weng, Yue
    Chittaboina, Srinivas
    Zhuo, Rupeng
    Harrell, Patina M.
    Trinh, Yenphuong T.
    Zhang, Qinghai
    Urbatsch, Ina L.
    Chang, Geoffrey
    [J]. SCIENCE, 2009, 323 (5922) : 1718 - 1722
  • [4] Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent
    Artis, Dean R.
    Lin, Jack J.
    Zhang, Chao
    Wang, Weiru
    Mehra, Upasana
    Perreault, Mylene
    Erbe, David
    Krupka, Heike I.
    England, Bruce P.
    Arnold, James
    Plotnikov, Alexander N.
    Marimuthu, Adhirai
    Nguyen, Hoa
    Will, Sarah
    Signaevsky, Maxime
    Kral, John
    Cantwell, John
    Settachatgull, Calvin
    Yan, Douglas S.
    Fong, Daniel
    Oh, Angela
    Shi, Shenghua
    Womack, Patrick
    Powell, Benjamin
    Habets, Gaston
    West, Brian L.
    Zhang, Kam Y. J.
    Milburn, Michael V.
    Vlasuk, George P.
    Hirth, K. Peter
    Nolop, Keith
    Bollag, Gideon
    Ibrahim, Prabha N.
    Tobin, James F.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (01) : 262 - 267
  • [5] Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome
    Barr, Alastair J.
    Ugochukwu, Emilie
    Lee, Wen Hwa
    King, Oliver N. F.
    Filippakopoulos, Panagis
    Alfano, Ivan
    Savitsky, Pavel
    Burgess-Brown, Nicola A.
    Mueller, Susanne
    Knapp, Stefan
    [J]. CELL, 2009, 136 (02) : 352 - 363
  • [6] The immunogenic CBD1 peptide corresponding to the caveolin-1 binding domain in HIV-1 envelope gp41 has the capacity to penetrate the cell membrane and bind caveolin-1
    Benferhat, Rima
    Sanchez-Martinez, Silvia
    Nieva, Jose L.
    Briand, Jean Paul
    Hovanessian, Ara G.
    [J]. MOLECULAR IMMUNOLOGY, 2008, 45 (07) : 1963 - 1975
  • [7] The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope
    Benferhat, Rima
    Martinon, Frederic
    Krust, Bernard
    Le Grand, Roger
    Hovanessian, Ara G. C.
    [J]. MOLECULAR IMMUNOLOGY, 2009, 46 (04) : 705 - 712
  • [8] A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice
    Bernatchez, Pascal
    Sharma, Arpeeta
    Bauer, Philip M.
    Marin, Ethan
    Sessa, William C.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (09) : 3747 - 3755
  • [9] Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides
    Bernatchez, PN
    Bauer, PM
    Yu, J
    Prendergast, JS
    He, PN
    Sessa, WC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) : 761 - 766
  • [10] Disruption of the maxi-K-caveolin-1 interaction alters current expression in human myometrial cells
    Brainard, Adam M.
    Korovkina, Victoria P.
    England, Sarah K.
    [J]. REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2009, 7